Quantification of conjunctival vascular reaction by digital imaging

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 3, 1996, Pages 495-500

  Horak, Friedrich ^a,d   Berger, Uwe ^a   Menapace, Reinhard ^b   Schuster, Norbert ^c  

^a University Hospital for Ear Nose Throat   (Austria)

^b University Eye Clinic   (Austria)

^c Olympus Optical (Europe) GmbH   (Germany)

^d ENT University Clinic   (Austria)

Author keywords

conjunctival allergic inflammation; Conjunctival provocation test; red density; vascular reaction; video equipment

Indexed keywords

AZELASTINE; EYE DROPS; HISTAMINE H1 RECEPTOR ANTAGONIST; PLACEBO;

ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GRASS POLLEN; HUMAN; IMAGE ANALYSIS; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; VIDEORECORDING;

EID: 0029998557     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70081-7     Document Type: Article

References (14)

1. Salzano FA, d'Angelo L, Motta S, del Prete A, Gentile M, Motta G. Allergie rhinoconjunctivitis: diagnostic and clinical assessment. Rhinology 1992;30:265-75.
2. Ciprandi G, Buscaglia S, Pescer GP, Iudice A, Bagnasco M, Canonica GW. Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test. Allergy 1993;48:421-30.
3. Escudero AI, Sanchez-Buerrero IM, Mora AM, et al. Cost effectiveness of various methods of diagnosing hypersensitivity to Alternaria. Allergol Immunopathol (Madr) 1993;21:153-7.
4. Leonardi A, Battista MC, Gismondi M, Fregona IA, Secchi AG. Antigen sensitivity evaluated by tear-specific and serum-specific IgE, skin test, and conjunctival and nasal provocation tests in patients with ocular allergic disease. Eye 1993;7:461-4.
5. Dreborg S, Frew A, editors. Position paper: allergen standardization and skin tests. Allergy 1993;14:48-82.
6. Horak F, Jäger S. Die Wiener Provokationskammer (Vienna Challenge Chamber). Eine neue Methode des Allergenexpositionstests. Wien Klin Wochenschr 1987;99:509-10.
7. Jäger S, Horak F. VCC - Vienna Challenge Chamber: pollen distribution. Allergy 1988;43 (suppl. 7):56.
8. Cartier A, Bernstein L, Sherwood Burge P. Guidelines for bronchoprovocation on the investigation of occupational asthma. J Allergy Clin Immunol 1989;84:823-9.
9. Cue-Series, Olympus a) Manual Galai Pd. Ltd. MT0008231 (1994) b) JQ Volume 19. Hamburg: Olympus Optical Co., 1994.
10. Hillier K. Azelastine. Drugs of the future. 1980;5:123-4.
11. Horak F, Berger U, Jäger S, Toth J. Rhinologische Anwendungen des Videoturms "Modell Wien" mit digitaler Bildverarbeitung. Zentralblatt HNO 1994;144:768-9.
12. Ciprandi G, Buscaglia S, Iudice A, Canonica GW, Protective effect of different doses of terfenadine on the conjunctival provocation test. Allergy 1992;47:309-12.
13. Ciprandi G, Buscaglia S, Pesce GP, Marchesi E, Canonica GW. Protective effect of loratadine on specific conjunctival provocation test. Int Arch Allergy Immunol 1991:96:344-7.
14. Rimas M, Gustafsson PM, Kjellman NI, Bjorksten B. Conjunctival provocation test: high clinical reproducibility but little local temperature change. Allergy 1992;47:324-6.